Incidence, economic burden, and treatment of acute respiratory tract infection in hematopoietic stem cell transplantation recipients using real world data in Japan: a retrospective claims data analysis.
Kittima WattanakamolkulYoshikazu NakayamaPublished in: Journal of medical economics (2022)
In HSCT recipients, ARTI leads to substantial incremental HCRU and direct costs for management in real-world settings in Japan.